AAM Voices of Access 2022
Tens of millions of Americans entrust their health to generics and biosimilars. This publication introduces you to some of them.
AAM Voices of Access
Your Voices, Your Health
AAM’s “Voices of Access” report features patients across the country speaking about the importance of generic and biosimilar medicines in their lives. This annual publication tells the impact that accessible medicines have on everyday Americans – on their health journeys, their economic well-being and their daily lives.
White Paper: Potential Savings from Accelerating U.S. Approval of Complex Generics
by Alex Brill, Founder and CEO, Matrix Global Advisors; Resident Fellow, American Enterprise Institute